MRK
Merck & Co., Inc.
Stock
$148.69−0.09 (−0.06%)Close Sep 28, 2026
| Operating cash flow (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $20.0B | +7.7% | 9.9% | 2.8% |
| Operating cash flow (TTM) | $20.0B |
|---|---|
| YoY | +7.7% |
| 5-year CAGR | 9.9% |
| 10-year CAGR | 2.8% |
Operating cash flow
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $16.5B | −23.3% |
| 2024 | $21.5B | +65.1% |
| 2023 | $13.0B | −31.9% |
| 2022 | $19.1B | — |
| 2020 | $10.3B | −23.7% |
| 2019 | $13.4B | +23.1% |
| 2018 | $10.9B | +69.3% |
| 2017 | $6.5B | −37.8% |
| 2016 | $10.4B | −17.2% |
| 2015 | $12.5B | +56.9% |
| 2014 | $8.0B | −31.4% |
| 2013 | $11.7B | +16.3% |
| 2012 | $10.0B | −19.1% |
| 2011 | $12.4B | +14.4% |
| 2010 | $10.8B | +219.0% |
| 2009 | $3.4B | −48.4% |
| 2008 | $6.6B | −6.1% |
| 2007 | $7.0B | — |